Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies

By afschroeder • November 23, 2025

Nel AE, Luo L, Liao YP, Wang X. Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies. ACS Nano. 2025 Nov 22. doi: 10.1021/acsnano.5c14753. Epub ahead of print. PMID: 41273281.

Tags: General Internal Medicine, immune adjuvant nanocarrier, immune tolerance, immunotherapy, lipid nanoparticle, mRNA, Nano Medicine, Pancreatic ductal adenocarcinoma (PDAC), Post Doc, Publications, reprogramming, tumor microenvironment

Population-Level Teleretinal Screening Bulk Orders to Improve Diabetic Retinopathy Screening Rates: A Randomized Quality Improvement Trial

Takimoto SW, Freeby M, Han M, Vangala S, Fujimoto J, Dermenchyan A, Lambrechts S. Population-Level Teleretinal Screening Bulk Orders to Improve Diabetic Retinopathy Screening Rates:[...]

Body composition changes during cardiac rehabilitation and long-term cardiovascular outcomes in patients with coronary artery disease

Kumar A, Van C, Shahrvini T, Srikanthan P, Horwich TB. Body composition changes during cardiac rehabilitation and long-term cardiovascular outcomes in patients with coronary artery[...]

The complement system in inflammatory bowel disease: from early observations to emerging frontiers

Ramirez Reyes B, Kulkarni D. The complement system in inflammatory bowel disease: from early observations to emerging frontiers. Curr Opin Gastroenterol. 2026 Jul 1;42(4):255-262. doi:[...]